238
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

In vitro evaluation of magnetite nanoparticles in human mesenchymal stem cells: comparison of different cytotoxicity assays

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 48-59 | Received 31 May 2019, Accepted 26 Jul 2019, Published online: 19 Aug 2019

References

  • Altman SA, Randers L, Rao G. 1993. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog. 9(6):671–674.
  • Babich H, Borenfreund E. 1990. Applications of the neutral red cytotoxicity assay to in vitro toxicology. Altern Lab Anim. 18:129–144.
  • Bakhtiary Z, Saei AA, Hajipour MJ, Raoufi M, Vermesh O, Mahmoudi M. 2016. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: possibilities and challenges. Nanomedicine. 12(2):287–307.
  • Bancos S, Tyner KM. 2014. Evaluating the effect of assay preparation on the uptake of gold nanoparticles by RAW264.7 cells. J Nanobiotechnology. 12:45. Available from: http://www.jnanobiotechnology.com/content/12/1/45
  • Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P. 2007. The reliability and limits of the MTT reduction assay for carbon nanotubescell interaction. Carbon. 45(13):2643–2648.
  • Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, Del Fante C, Novara F, de Silvestri A, Amendola G, et al. 2007. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol. 211(1):121–130.
  • Borenfreund E, Puerner JA. 1985a. Simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR90). J Tissue Cult Methods. 9(1):7–9.
  • Borenfreund E, Puerner JA. 1985b. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 24(2-3):119–124.
  • Bosch J, Houben AP, Radke TF, Stapelkamp D, Bünemann E, Balan P, Buchheiser A, Liedtke S, Kögler G. 2012. Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?” Stem Cells Dev. 21(11):1977–1988.
  • Braun K, Christina Stürzel M, Biskupek J, Kaiser U, Kirchhoff F, Lindén M. 2018. Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles. Toxicol in Vitro. 52:214–221.
  • Brüstle I, Simmet T, Nienhaus GU, Landfester K, Mailänder V. 2015. Hematopoietic and mesenchymal stem cells: polymeric nanoparticle uptake and lineage differentiation. Beilstein J Nanotechnol. 6:383–395.
  • Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47(4):936–942.
  • Casey A, Herzog E, Davoren M, Lyn FM, Byrne HJ, Chambers G. 2007. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon. 45(7):1425–1432.
  • Coccini T, Caloni F, Ramírez Cando LJ, De Simone U. 2017. Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short- and long-term exposure to magnetite nanoparticles. J Appl Toxicol. 37(3):361–373.
  • Coccini T, De Simone U, Roccio M, Croce S, Lenta E, Zecca M, Spinillo A, Avanzini MA. 2019. Species-specific in vitro model for toxicity screening of Fe3O4 nanoparticle: effects on mesenchymal stem cells derived from human umbilical cord lining. J Appl Toxicol. 1–17.
  • Commission Directive 2000/33/EC of 25 April 2000 adapting to technical progress for the 27th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance.) B. 41. Phototoxicity-in vitro 3T3 NRU phototoxicity test. OJ L 136, 8.6.2000, 90–107.
  • Costa C, Brandão F, Bessa MJ, Costa S, Valdiglesias V, Kiliç G, Fernández-Bertólez N, Quaresma P, Pereira E, Pásaro E, et al. 2016. In vitro cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests. J Appl Toxicol. 36(3):361–372.
  • Dassler K, Roohi F, Lohrke J, Ide A, Remmele S, Hütter J, Pietsch H, Pison U, Schütz G. 2012. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles. Invest Radiol. 47(7):383–391.
  • Davoren ME, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM. 2007. In vitro toxicity evaluation of singlewalled carbon nanotubes on human A549 lung cells. Toxicol in Vitro. 21(3):438–448.
  • De Simone U, Caloni F, Gribaldo L, Coccini T. 2017. Human co-culture model of neurons and astrocytes to test acute cytotoxicity of neurotoxic compounds. Int J Toxicol. 36(6):463–477.
  • Doak SH, Griffiths SM, Manshian B, Singh N, Williams PM, Brown AP, Jenkins GJ. 2009. Confounding experimental considerations in nanogenotoxicology. Mutagenesis. 24(4):285–293.
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8(4):315–317.
  • Drasler B, Sayre P, Steinhäuser KG, Petri-Fink A, Rothen-Rutishauser B. 2017. In vitro approaches to assess the hazard of nanomaterials. NanoImpact. 8:99–116.
  • Dulińska-Litewka J, Łazarczyk A, Hałubiec P, Szafrański O, Karnas K, Karewicz A. 2019. Superparamagnetic iron oxide nanoparticles - Current and prospective medical applications. Materials (Basel). 12(4):617.
  • Duschl A, Windgasse G. 2018. A survey on the state of nanosafety research in the European Union and the United States. J Nanopart Res. 20(12):335.
  • Everitt BS, Skrondal A. 2010. The Cambridge dictionary of statistics fourth edition. Cambridge (UK): Cambridge University Press
  • Fan JH, Li WT, Hung WI, Chen CP, Yeh JM. 2011. Cytotoxicity and differentiation effects of gold nanoparticles to human bone marrow mesenchymal stem cells. Biomed Eng Appl Basis Commun). 23(2):141–152.
  • Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, Guerin M. 2009. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol in Vitro. 23(4):697–703.
  • Fröhlich E. 2018. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles. Artif Cells Nanomed Biotechnol. 46(sup2):1091–1107.
  • Griffiths SM, Singh N, Jenkins GJ, Williams PM, Orbaek AW, Barron AR, Wright CJ, Doak SH. 2011. Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem. 83(10):3778–3785.
  • Gupta AK, Gupta M. 2005. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 26(18):3995–4021.
  • Gutierrez AM, Dziubla TD, Hilt JZ. 2017. Recent advances on iron oxide magnetic nanoparticles as sorbents of organic pollutants in water and wastewater treatment. Rev Environ Health. 32(1-2):111–117.
  • Hachani R, Birchall MA, Lowdell MW, Kasparis G, Tung LD, Manshian BB, Soenen SJ, Gsell W, Himmelreich U, Gharagouzloo CA, et al. 2017. Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging. Sci Rep. 7(1):7850.
  • Harrison R, Markides H, Morris RH, Richards P, El Haj AJ, Sottile V. 2017. Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications. J Tissue Eng Regen Med. 11(8):2333–2348.
  • He W, Liu X, Kienzle A, Müller WE, Feng Q. 2016. In vitro uptake of silver nanoparticles and their toxicity in human mesenchymal stem cells derived from bone marrow. J Nanosci Nanotechnol. 16(1):219–228.
  • Heo JS, Lim JY, Pyo S, Yoon DW, Lee D, Ren WX, Lee SG, Kim GJ, Kim J. 2019. Environmental benzopyrene attenuates stemness of placenta-derived mesenchymal stem cells via aryl hydrocarbon receptor. Stem Cells Int. 2019:7414015.
  • Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW. 2011. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine. 6:3219–3231.
  • Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H. 2009. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem. 108(2):529–535.
  • ICCVAM 2006a. Background review document: in vitro basal cytotoxicity test methods for estimating acute oral systemic toxicity. Research Triangle Park, NC: National Institute for Environmental Health Sciences.
  • ICCVAM 2006b. Test Method Evaluation Report (TMER): in vitro cytotoxicity test methods for estimating starting doses for acute oral systemic toxicity testing. Research Triangle Park, NC: National Institute of Environmental Health Sciences.
  • Ito A, Shinkai M, Honda H, Kobayashi T. 2005. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng. 100(1):1–11.
  • Jasmin, Souza GT, Louzada RA, Rosado-de-Castro PH, Mendez-Otero R, Carvalho ACC. 2017. Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine. Volume 12:779–793.
  • Keene AM, Bancos S, Tyner KM. 2014. Considerations for in vitro nanotoxicology testing. In: Sahu SC, Casciano DA, eds. Handbook of nanotoxicology, nanomedicine and stem cell use in toxicology. Chichester: John Wiley & Sons Inc.
  • Kitambi SS, Chandrasekar G. 2011. Stem cells: a model for screening, discovery and development of drugs. Stem Cells Cloning. 4:51–59.
  • Kornberg TG, Stueckle TA, Antonini JA, Rojanasakul Y, Castranova V, Yang Y, Wang L. 2017. Potential toxicity and underlying mechanisms associated with pulmonary exposure to iron oxide nanoparticles: conflicting literature and unclear risk. Nanomaterials (Basel). 7(10):307.
  • Kumar V, Sharma·N, Maitra SS. 2017. In vitro and in vivo toxicity assessment of nanoparticles. Int Nano Lett. 7(4):243–256.
  • Laaksonen T, Santos H, Vihola H, Salonen J, Riikonen J, Heikkilä T, Peltonen L, Kumar N, Murzin DY, Lehto VP, et al. 2007. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. Chem Res Toxicol. 20(12):1913–1918.
  • Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. 2008. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 108(6):2064–2110.
  • Laurent S, Dutz S, Häfeli UO, Mahmoudi M. 2011. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 166(1-2):8–23.
  • Laurent S, Saei AA, Behzadi S, Panahifar A, Mahmoudi M. 2014. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv. 11(9):1449–1470.
  • Li XX, Li KA, Qin JB, Ye KC, Yang XR, Li WM, Xie QS, Jiang ME, Zhang GX, Lu XW. 2013. In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia. Int J Nanomedicine. 8:1063–1073.
  • Liu X, Zhong Z, Tang Y, Liang B. 2013. Review on the synthesis and applications of Fe3O4 nanomaterials. J Nanomater. 2013:7.
  • Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. 2011. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 63(1-2):24–46.
  • Mancuso L, Cao G. 2014. Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells. Toxicol Mech Methods. 24(7):449–454.
  • Mancuso L, Manis C, Murgia A, Isola M, Salis A, Piras F, Caboni P, Cao G. 2018. Effect of ZnO nanoparticles on human bone marrow mesenchymal stem cells: viability, morphology, particles uptake, cell cycle and metabolites. Biosci Biotech Res Asia. 15(4):751–765.
  • Merlin JL, Azzi S, Lignon D, Ramacci C, Zeghari N, Guillemin F. 1992. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer. 28(8-9):1452–1458.
  • Mohanty S, Jain KG, Nandy SB, Kakkar A, Kumar M, Dinda AK, Singh H, Ray A. 2018. Iron oxide labeling does not affect differentiation potential of human bone marrow mesenchymal stem cells exhibited by their differentiation into cardiac and neuronal cells. Mol Cell Biochem. 448(1-2):17–26.
  • Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon. 44(6):1070–1078.
  • Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 234(2):222–235.
  • Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65(1-2):55–63.
  • Nirmalanandhan VS, Sittampalam GS. 2009. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. J Biomol Screen. 14(7):755–768.
  • Organisation for Economic Co-operation and Development. 2004. OECD guideline for testing of chemicals: In vitro 3T3 NRU phototoxicity test. no. 432 (original guideline, adopted 13th April 2004) [accessed 2019 Jul 11]. https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg432-508.pdf
  • Periasamy VS, Athinarayanan J, Alhazmi M, Alatiah KA, Alshatwi AA. 2014. Fe3O4 nanoparticle redox system modulation via cell-cycle progression and gene expression in human mesenchymal stem cells . Environ Toxicol. 31(8):901–912.
  • Periasamy VS, Athinarayanan J, Alshatwi AA. 2016. Aluminum oxide nanoparticles alter cell cycle progression through CCND1 and EGR1 gene expression in human mesenchymal stem cells. Biotechnol Appl Biochem. 63(3):320–327.
  • Piccinini F, Tesei A, Arienti C, Bevilacqua A. 2017. Cell counting and viability assessment of 2D and 3D cell cultures: expected reliability of the trypan blue assay. Biol Proced Online. 19(1):8.
  • Repetto G, del Peso A, Zurita JL. 2008. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 3(7):1125–1131.
  • Sanganeria P, Chandra S, Bahadur D, Khanna A. 2015. Effect of HSA coated iron oxide labeling on human umbilical cord derived mesenchymal stem cells. Nanotechnology. 26(12):125103.
  • Scanu M, Mancuso L, Cao G. 2011. Evaluation of the use of human mesenchymal stem cells for acute toxicity tests. Toxicol in Vitro. 25(8):1989–1995.
  • Scotter MJ. 2011. Methods for the determination of European Union-permitted added natural colours in foods: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 28(5):527–596.
  • Shahbazzadeh D, Ahari H, Motalebi AA, Anvar AA, Moaddab S, Asadi T, Shokrgozar MA, Rahman-Nya J. 2011. In vitro effect of nanosilver toxicity on fibroblast and mesenchymal stem cell lines. Iran J Fish Sci. 10(3):487–496.
  • Singh N, Jenkins GJ, Asadi R, Doak SH. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1. DOI: 10.3402/nano.v1i0.5358
  • Soenen SJ, De Cuyper M. 2009. Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging. 4(5):207–219.
  • Strobe W. 2001. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. Appendix-3:B1–B2.
  • Thakor AS, Jokerst JV, Ghanouni P, Campbell JL, Mittra E, Gambhir SS. 2016. Clinically approved nanoparticle imaging agents. J Nuclear Med. 57(12):1833–1837.
  • Thiede MA. 2009. Stem cell applications and opportunities in drug discovery. Therapeutics. Available from: https://www.ddw-online.com/therapeutics/p92862-stem-cell-applications-and-opportunities-in-drug-discovery.html
  • van Meerloo J, Kaspers GJ, Cloos J. 2011. Cell sensitivity assays: the MTT assay. Methods Mol Biol. 731:237–245.
  • World Health Organization, Food and Agriculture Organization of the United Nations & Joint FAO/WHO Expert Committee on Food Additives. Meeting (74th: 2011: Rome, Italy). (2011). Evaluation of certain food additives and contaminants: seventy-fourth [74th] report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization. WHO technical report series; no. 966. https://apps.who.int/iris/handle/10665/44788
  • Yen SK, Padmanabhan P, Selvan ST. 2013. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics. 3(12):986–1003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.